On 8 April 2010 Biopartners GmbH announced that it had received EU marketing authorisation from the European Commission for Ribavirin Biopartners 200mg film-coated tablets. The product is intended for the treatment of chronic hepatitis C infection as part of a combination regimen with peginterferon alfa-2b interferon alfa-2b.
NDA, the leading European regulatory affairs consulting group, appoints Dr Panos Tsintis to its expanding panel of experts - the NDA Advisory Board.
Benzbromaron is one of the main uricosuric drugs currently used. In addition to sophisticated and expensive LC-MS and GC-MS methods, benzbromaron can be effectively determined by titration with sodium hydroxide solution using straightforward, fully automated sample preparation. For the latter, the 815 Robotic Soliprep is the perfect instrument.
No other industry is as thoroughly regulated as the pharmaceutical industry. The active ingredients are legion and so are the standards to test for them. Metrohm's new brochure "Pharmaceutical analysis" is a highly valuable compendium that gives an overall view of the most important parameters determining the quality of pharmaceuticals and the methods best suited to check them.
Secure shipping service for international companies expanding in Russia.
Innovaro, a comprehensive innovation solution company, is pleased to announce the formation of Verdant Ventures Advisors, LLC, an independently managed technology transfer venture fund.
UTEK Corporation, a leading IP licensing and innovation services company, is pleased to announce a partnership between MEDEC and MedilinkUK and its online licensing marketplaces, Pharmalicensing and Medical Device Licensing. Through this partnership, hundreds of new companies can take advantage of UTEK’s growing network of registered companies and industry professionals, all looking to identify licensing and partnering opportunities worldwide.
UTEK Corporation, a leading IP licensing and innovation services company, and Patents.com, one of the worlds most comprehensive sources of patent data, announce today a partnership, bringing their clients enhanced services.
UTEK Corporation, a leading IP licensing and innovation services company, is pleased to announce a new pricing model for its Pharmalicensing online service; the pricing will be effective starting 13 January.
Rescentris today announced iPad and iPhone platform clients to extend mobile use of its award-winning CERF Electronic Laboratory Notebook (ELN).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.